Plain-English translation of NCT06533163 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a device called the Oncomagnetic Device, which uses low-intensity oscillatory magnetic therapy to treat newly diagnosed glioblastoma (a type of brain cancer). Researchers want to see if this treatment is safe and how well patients tolerate it when they gradually increase their daily exposure time over several weeks.
Glioblastoma is an aggressive brain cancer that is very difficult to treat, and doctors are looking for new approaches to improve outcomes for patients. This trial is exploring whether this magnetic therapy device could be a helpful addition to standard cancer treatment.
You likely qualify if…
You likely don't qualify if…
You would use the magnetic therapy device starting at 4 hours per day. Every 2 weeks, if you have no concerning side effects, the treatment time increases—first to 6 hours, then to 8 hours per day, where it stays for the rest of the study. If you experience problems, your doctor can reduce the treatment time back to a lower, safer level. Throughout the study, your medical team will monitor you closely with regular MRI scans and visits to make sure the treatment is working safely.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
Germany